Jody C. Chuang - Concepedia

Author

Jody C. Chuang

University of Southern California

Also Known As

Chuang, Jody Chouying (author), Jody C Chuang, Jody C. Chuang, Jody Chuang

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Southern California Center for Cancer Research Frederick National Laboratory for Cancer Research National Cancer Institute Stanford Health Care

About

Jody C. Chuang is an author at University of Southern California specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	2.1K
2	Cell Biology	5	5	2K
3	Pathology	2	2	135
4	Pharmacology	2	2	135
5	Cancer Cell Biology	1	1	36

Jody C. Chuang

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Yoshimasa Saito, Gangning Liang, Gerda Egger, Cancer Cell Tumor BiologyProto-oncogene Bcl6MedicineOncogenic AgentMicrorna Detection	2006	1.3K
Preferential response of cancer cells to zebularine Jonathan Cheng, Christine B. Yoo, Daniel J. Weisenberger, Cancer Cell Tumor BiologyMedicineCancer CellsCancer BiologyCell Biology	2004	313
Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells Yoshimasa Saito, Jeffrey M. Friedman, Yoshitomo Chihara, Biochemical and Biophysical Research Communications Tumor Suppressor Microrna-126MedicineEpigenetic TherapyMicrorna DetectionHost Gene Egfl7	2008	241
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine Jody C. Chuang, Christine B. Yoo, Jennifer M. Kwan, Molecular Cancer Therapeutics	2005	204
Molecular profiling reveals synaptic release machinery in Merkel cells Henry Haeberle, Mika Fujiwara, Jody C. Chuang, Proceedings of the National Academy of Sciences	2004	190
S110, a 5-Aza-2′-Deoxycytidine–Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor <i>In vivo</i> and Can Reduce Tumor Growth Jody C. Chuang, Steven L. Warner, David Vollmer, Molecular Cancer Therapeutics	2010	151
Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice Christine B. Yoo, Jody C. Chuang, Hyang‐Min Byun, Cancer Prevention Research Drinking WaterEpigenetic RegulationDna Methylation InhibitorsMedicineDna Methylation	2008	99
ERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies Jody C. Chuang, Henning Stehr, Ying Liang, Journal of Thoracic Oncology MedicineTargeted TherapiesCell BiologyCancer TreatmentCancer Genetics	2017	92
Crizotinib as first line therapy for advanced ALK-positive non-small cell lung cancers. Jody C. Chuang, Joel W. Neal PubMed PathologyNsclc TumorsTargeted Therapeutic DevelopmentCancer BiologyTumor Biology	2015	36
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy Matthew A. Gubens, Jody C. Chuang, Wallace Akerley, Journal of Thoracic Disease	2018	11

Page 1